Restylane Kysse has been approved in Korea

Optional Balanced Technology (OBT) for customized procedures

Young to middle-aged people are very satisfied

Galderma Korea announced on the 2nd that Hyaluronic acid filler Restylane Kysse was approved by the MFDS on July 26 for the purpose of temporarily expanding the volume of lips for adults aged 21 or older.

 

Restylane Kysse, which received Korea's first permission for lip fillers, was developed by Galderma as Optical Balanced Technology( OBT).

 

Customized procedures can be performed to suit the patient's skin condition, and lip volume can be restored to create natural and beautiful lip volume.

 

More than 78% of all patients who participated in Restylane Kysse's clinical trial said they were still satisfied with the results of the procedure a year later.

 

The effect of Restylane Kysse was confirmed by a clinical trial.

 

A total of 270 people were evaluated for the validity and satisfaction of the product by measuring changes after the lip enlargement procedure every eight weeks for 12 months.

 

Clinical results showed that it lasted up to a year and showed high treatment satisfaction not only in middle-aged people who lost lip volume due to aging but also in young patients who wanted natural and thick lips.

 

Based on this, it was approved by the FDA on March 26 last year as a lip filler.

 

Lee Jae-hyuk, executive director of Galderma Korea's Aesthetic Division, said, "We reaffirmed the technical skills of Galderma, which developed the Hyaluronic acid filler Restylane Kysse.

 

We will continue to make efforts as a helper to complete each person's skin through products like Restylane Kysse.

 

We have been constantly innovating for healthy and beautiful skin."